Literature DB >> 8079812

Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors.

Z Tömösközi1, G Bugovics, S Koncz, P Arányi.   

Abstract

The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Arg residues with the specific reagent 1,2-cyclohexanedione. It was found that chemical modification of Arg residues decreased the binding potential of IL-1 beta to type I receptor dramatically (by 230-fold) while the affinity to type II receptor was reduced only moderately (by 10-fold), with an insignificant reduction of the dissociation rate. These studies suggest that intact Arg side chains of IL-1 beta may be necessary for high affinity binding to type I IL-1 receptor, but have less importance for the interaction of IL-1 beta with type II IL-1 receptor. This observation may be useful in the study of type II IL-1 receptor-mediated biological responses and design of receptor-subtype specific ligands as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079812     DOI: 10.1007/bf01986407

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

Authors:  L J Rosenwasser; C A Dinarello
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

2.  Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues.

Authors:  L Patthy; E L Smith
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

3.  Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli.

Authors:  P Wingfield; M Payton; J Tavernier; M Barnes; A Shaw; K Rose; M G Simona; S Demczuk; K Williamson; J M Dayer
Journal:  Eur J Biochem       Date:  1986-11-03

4.  A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.

Authors:  L Gehrke; S A Jobling; L S Paik; B McDonald; L J Rosenwasser; P E Auron
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

Review 5.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

6.  Muteins of human interleukin-1 that show enhanced bioactivities.

Authors:  J J Huang; R C Newton; R Horuk; J B Matthew; M Covington; K Pezzella; Y A Lin
Journal:  FEBS Lett       Date:  1987-11-02       Impact factor: 4.124

7.  The role of arginine residues in interleukin 1 receptor binding.

Authors:  V B Nanduri; J D Hulmes; Y C Pan; P L Kilian; A S Stern
Journal:  Biochim Biophys Acta       Date:  1991-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.